Literature DB >> 6519755

Regression of retinal vascular changes by antihypertensive therapy.

K D Bock.   

Abstract

The features of hypertensive retinal arterial vessel changes and their sequelae are reviewed. General or focal narrowing, increased reflexes or abnormal arteriovenous crossings, are often associated with, but not specific for, hypertension. They persist, with very rare exceptions, even after long-term successful antihypertensive therapy. Papilledema, cotton-wool spots, hemorrhages, and fatty exudates in malignant hypertension disappear completely within 6 to 12 months if blood pressure is well controlled. Inadequate control of elevated blood pressure delays, but does not prevent, the regression of retinopathy. The reversal into the "benign" phase may continue for years, even if blood pressure control worsens. This may be explained by a regain of autoregulation which allows the arteriolonecrotic lesions to heal. According to their size, retinal arteries are representative of the target organ of hypertensive small vessel disease. They supply a tissue that is highly sensitive to ischemia. However, even long-standing nonmalignant hypertension seems not to damage retinal tissue.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6519755     DOI: 10.1161/01.hyp.6.6_pt_2.iii158

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

1.  [Remission of chronic kidney diseases. A realistic goal?].

Authors:  Gert Mayer
Journal:  Wien Klin Wochenschr       Date:  2003-07-15       Impact factor: 1.704

Review 2.  Hypertensive retinopathy revisited: some answers, more questions.

Authors:  A Grosso; F Veglio; M Porta; F M Grignolo; T Y Wong
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

3.  Hypertensive retinopathy and risk of cardiovascular diseases in a national cohort.

Authors:  M Fareed K Suri; Adnan I Qureshi
Journal:  J Vasc Interv Neurol       Date:  2008-07

Review 4.  Impact of arterial hypertension on the eye.

Authors:  Vasiliki Katsi; Maria Marketou; Charalambos Vlachopoulos; Dimitris Tousoulis; George Souretis; Nikolaos Papageorgiou; Christodoulos Stefanadis; Panos Vardas; Ioannis Kallikazaros
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

5.  Ten-year longitudinal changes in retinal microvascular lesions: the atherosclerosis risk in communities study.

Authors:  Gerald Liew; Stephen Campbell; Ronald Klein; Barbara E K Klein; A Richey Sharrett; Mary Frances Cotch; Jie Jin Wang; Tien Y Wong
Journal:  Ophthalmology       Date:  2011-04-29       Impact factor: 12.079

6.  Tremendous result of bevacizumab in malignant hypertensive retinopathy.

Authors:  Ali M Al-Halafi
Journal:  Oman J Ophthalmol       Date:  2015 Jan-Apr

7.  Effects of Dietary Supplementation with Sea Buckthorn (Hippophae rhamnoides L.) Seed Oil on an Experimental Model of Hypertensive Retinopathy in Wistar Rats.

Authors:  Konstantinos Bouras; Konstantinos Kopsidas; Michael Bariotakis; Paraskevi Kitsiou; Katerina Kapodistria; Giorgos Agrogiannis; Ioannis Vergados; Panagiotis Theodossiadis; Despoina Perrea
Journal:  Biomed Hub       Date:  2017-03-01

8.  The clinical assessment of retinal microvascular structure and therapeutic implications.

Authors:  Alun D Hughes
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-06

9.  Systemic microvascular rarefaction is correlated with dysfunction of late endothelial progenitor cells in mild hypertension: a substudy of EXCAVATION-CHN1.

Authors:  Jianwen Liang; Yan Li; Long Chen; Wenhao Xia; Guifu Wu; Xinzhu Tong; Chen Su; Jiang He; Xiufang Lin; Jun Tao
Journal:  J Transl Med       Date:  2019-11-12       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.